Abcam, ab283232, Anti-SLFN11 antibody [EPR24414-87] - BSA and Azide free

Size: 100µg / 1mg
Rabbit Recombinant Monoclonal SLFN11 antibody. Carrier free. Suitable for ICC/IF, IP, WB, IHC-P, Flow Cyt (Intra) and reacts with Human samples.
Key facts
Host species:Rabbit,
Clonality:Monoclonal,
Clone number:EPR24414-87,
Isotype:IgG,
Carrier free:Yes,
Reacts with:Human,
Applications:ICC/IF, WB, IP, Flow Cyt (Intra), IHC-PSee reactivity dataSee the reactivity data table below for information on validated species and application combinations.,
Immunogen:The exact immunogen used to generate this antibody is proprietary information.

Product details:
ab283232 is the carrier-free version of
ab271354
Patented technology
Our RabMAb
technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to
RabMAb® patents
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- High batch-to-batch consistency and reproducibility
- Improved sensitivity and specificity
- Long-term security of supply
- Animal-free batch production
For more information, read more on
recombinant antibodies
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our
conjugation kits
for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar
Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar
is a trademark of Fluidigm Canada Inc.

Properties and Storage Information:
Form-Liquid, Purification technique-Affinity purification Protein A, Storage buffer-pH: 7.2 - 7.4Constituents: PBS, Shipped at conditions-Blue Ice, Appropriate short-term storage conditions-+4°C, Appropriate long-term storage conditions-+4°C

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
SLFN11 also known as Schlafen family member 11 is an important protein involved in the regulation of cellular response to DNA damage. With a molecular mass of approximately 104 kDa SLFN11 is extensively expressed in tumor cells and certain normal tissues particularly in the spleen thymus and testis. This protein contributes to the modulation of interferon-mediated immune responses and impacts translational control by tRNA activation playing a role in ribosomal assembly and function.
Biological function summary
SLFN11 functions to enhance the sensitivity of cells to DNA-damaging agents including chemotherapeutic drugs. It is important for impairing replication fork stability by inhibiting the expression of trans-translation machinery. SLFN11 serves as an important determinant within the DNA damage response (DDR) network and is known to interact with other DDR proteins emphasizing its impact on genome integrity and cellular survival under stress conditions.
Pathways
SLFN11 plays a notable role within the pathways associated with the DNA damage response and cell cycle regulation. The protein interacts notably with the ATR signaling pathway which is essential for sensing DNA damage. Additionally SLFN11 forms part of a complex interaction with other DNA repair proteins such as BRCA1 influencing the homologous recombination repair pathway contributing to the cellular determination of treatment response.
SLFN11 has significant implications in cancer particularly in the context of treatment response to chemotherapy. Cancers with high SLFN11 expression often exhibit increased sensitivity to cisplatin and other DNA-damaging agents pointing to its potential role as a biomarker for therapeutic efficacy. Moreover the protein is implicated in neurodegenerative disorders like amyotrophic lateral sclerosis (ALS) where its regulation could contribute to the pathophysiology. Its relationship with proteins such as p53 further highlights SLFN11's involvement in cancer and neuroprotection pathways.